Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Horwitz

Showing results (671-680 of 717) with videos related to

Pageof 72
Sort By:
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Plos One|January 6, 2016
Can Emotional and Behavioral Dysregulation in Youth Be Decoded from Functional Neuroimaging?Liana C L Portugal, Maria João Rosa, Anil Rao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Non-Hodgkin's lymphomas, version 1.2013Andrew D Zelenetz, William G Wierda, Jeremy S Abramson, et al.
Blood Advances|April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapyWilliam T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Non-Hodgkin's lymphomas, version 2.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in OncologySteven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Non-Hodgkin's Lymphomas, version 3.2012Andrew D Zelenetz, William G Wierda, Jeremy S Abramson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Nature Medicine|June 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trialSteven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Prostate Cancer, Version 1.2016James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Pageof 72

Showing results (671-680 of 717) with videos related to

Sort By:
Pageof 72
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Plos One|January 6, 2016
Can Emotional and Behavioral Dysregulation in Youth Be Decoded from Functional Neuroimaging?Liana C L Portugal, Maria João Rosa, Anil Rao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 15, 2013
Non-Hodgkin's lymphomas, version 1.2013Andrew D Zelenetz, William G Wierda, Jeremy S Abramson, et al.
Blood Advances|April 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapyWilliam T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Non-Hodgkin's lymphomas, version 2.2014Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in OncologySteven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Non-Hodgkin's Lymphomas, version 3.2012Andrew D Zelenetz, William G Wierda, Jeremy S Abramson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015Andrew D Zelenetz, Leo I Gordon, William G Wierda, et al.
Nature Medicine|June 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trialSteven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Prostate Cancer, Version 1.2016James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Pageof 72